| Nov 5 |
Moderna CEO Bancel steps down as sales chief, Bloomberg News reports
|
| Nov 5 |
Bancel to step down as Moderna chief commercial officer, remain CEO
|
| Nov 5 |
Novavax (NVAX) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
| Nov 5 |
Carisma Therapeutics to Present New Data on Anti-GPC3 In Vivo CAR-M Therapy for Hepatocellular Carcinoma at SITC 2024
|
| Nov 5 |
Should Moderna Stock Be in Your Portfolio Pre-Q3 Earnings?
|
| Nov 4 |
Moderna (MRNA) Q3 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
|
| Oct 31 |
Moderna (MRNA) Stock Moves -0.66%: What You Should Know
|
| Oct 31 |
These 10 Stocks Were S&P 500's Top Performers In Biden's First Year: Could Trend Continue If Harris Wins 2024 Election?
|
| Oct 31 |
Moderna (MRNA): Expanding Horizons in Gene Editing and mRNA Vaccines
|
| Oct 31 |
Is Moderna (NASDAQ:MRNA) Stock a Buy at Current Levels?
|
